Watchlist Price Alert

BioXcel Therapeutics Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

1.71

0.18 (11.76%)

At close: Jun 06, 2025, 1:45 PM

BioXcel Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-59.6M	-179.05M	-165.76M	-106.93M	-82.17M	-32.97M	-19.27M	-4.54M	-2.12M
Depreciation & Amortization	309K	318K	327K	297K	188K	156K	17K	1K	n/a
Stock-Based Compensation	6.16M	18.61M	17.34M	19.45M	14.61M	3.14M	3.08M	1.61M	671K
Other Working Capital	-2.95M	5.07M	-123K	130K	-2.01M	-1.19M	-539K	-1K	-1K
Other Non-Cash Items	-12.86M	3.1M	2.08M	46K	14.99M	3.45M	3.12M	1.61M	671K
Deferred Income Tax	n/a	n/a	n/a	n/a	-14.99M	-3.45M	n/a	n/a	n/a
Change in Working Capital	-6.03M	2.02M	10.67M	4.98M	1.02M	2.39M	2.66M	736K	155K
Operating Cash Flow	-72.03M	-155.01M	-135.34M	-82.15M	-66.35M	-27.28M	-13.51M	-2.2M	-1.29M
Capital Expenditures	n/a	-20K	-139K	-445K	-316K	-870K	-340K	n/a	-4K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	-870K	-340K	n/a	n/a
Investing Cash Flow	n/a	-20K	-139K	-445K	-316K	-870K	-340K	n/a	-4K
Debt Repayment	-2.5M	n/a	98.6M	n/a	n/a	n/a	-371K	438K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	-9.02M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-54K	-207K	-2.36M	1.45M	598K	201K	-615K	584K	1.3M
Financial Cash Flow	36.66M	26.52M	96.24M	102.45M	247.36M	18.01M	55.53M	3.08M	1.3M
Net Cash Flow	-35.37M	-128.5M	-39.24M	19.85M	180.69M	-10.14M	41.68M	887K	n/a
Free Cash Flow	-72.03M	-155.03M	-135.48M	-82.6M	-66.67M	-28.15M	-13.85M	-2.2M	-1.3M